Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin as adjunctive treatment for hospitalized patients with mild to moderate COVID-19
IRCT20200408046990N3Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Mashhad University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20200408046990N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N3.